Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues
出版年份 2015 全文链接
标题
Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues
作者
关键词
-
出版物
CANCER
Volume 121, Issue 18, Pages 3290-3297
出版商
Wiley
发表日期
2015-06-06
DOI
10.1002/cncr.29471
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Sunitinib as second-line treatment in patients with advanced intrahepatic cholangiocarcinoma (SUN-CK phase II trial): Safety, efficacy, and updated translational results.
- (2015) Cindy Neuzillet et al. JOURNAL OF CLINICAL ONCOLOGY
- Second-line chemotherapy in advanced biliary cancer: a systematic review
- (2014) A. Lamarca et al. ANNALS OF ONCOLOGY
- Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
- (2014) L Fornaro et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
- (2014) David Malka et al. LANCET ONCOLOGY
- Efficacy of gemcitabine plus platinum agents for biliary tract cancers
- (2013) Rui Yang et al. ANTI-CANCER DRUGS
- A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
- (2013) Eiichiro Suzuki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Second-line therapy in advanced biliary tract cancer: What should be the standard?
- (2013) Stefano Cereda et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- A phase II FOLFOX-4 regimen as second-line treatment in advanced biliary tract cancer refractory to gemcitabine/cisplatin
- (2013) Shengli He et al. JOURNAL OF CHEMOTHERAPY
- Outcome of second-line chemotherapy for biliary tract cancer
- (2012) John Bridgewater et al. EUROPEAN JOURNAL OF CANCER
- Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study
- (2012) Thomas Walter et al. EUROPEAN JOURNAL OF CANCER
- Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer
- (2012) Kyu-Hyoung Lim et al. ONCOLOGY
- A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
- (2011) Jun Ho Yi et al. EUROPEAN JOURNAL OF CANCER
- Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
- (2011) Jeeyun Lee et al. LANCET ONCOLOGY
- Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer
- (2010) Takashi Sasaki et al. INVESTIGATIONAL NEW DRUGS
- Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine
- (2010) Takashi Sasaki et al. INVESTIGATIONAL NEW DRUGS
- A Phase II Study of Outpatient Biweekly Gemcitabine-Oxaliplatin in Advanced Biliary Tract Carcinomas
- (2010) A. Halim et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Best Supportive Care Compared With Chemotherapy for Unresectable Gall Bladder Cancer: A Randomized Controlled Study
- (2010) Atul Sharma et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Second-Line Treatment With a Combination of Continuous 5-Fluorouracil, Doxorubicin, and Mitomycin-C (Conti-Fam) in Gemcitabine-Pretreated Pancreatic and Biliary Tract Cancer
- (2009) Suee Lee et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
- (2009) C Bengala et al. BRITISH JOURNAL OF CANCER
- Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers
- (2009) Maria S. Pino et al. ONCOLOGY
- S-1 Monotherapy in Patients with Advanced Biliary Tract Cancer
- (2009) Takashi Sasaki et al. ONCOLOGY
- Gemcitabine-based versusfluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
- (2008) Mi-Jung Kim et al. BMC CANCER
- Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study
- (2008) T André et al. BRITISH JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started